PYR Fundamental Analysis - PYRUM INNOVATIONS AG

Fundamental Rating

Overall PYR gets a fundamental rating of 2 out of 10. We evaluated PYR against 42 industry peers in the Commercial Services & Supplies industry. PYR may be in some trouble as it scores bad on both profitability and health. PYR is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PYR has reported negative net income.

In the past year PYR has reported a negative cash flow from operations.

In the past 5 years PYR always reported negative net income.

In the past 5 years PYR always reported negative operating cash flow.

1.2 Ratios

PYR's Return On Assets of -16.30% is on the low side compared to the rest of the industry. PYR is outperformed by 78.57% of its industry peers.

PYR has a Return On Equity of -55.22%. This is in the lower half of the industry: PYR underperforms 76.19% of its industry peers.

		Industry Rank	Sector Rank
ROA	-16.3%
ROE	-55.22%
ROIC	N/A

ROA(3y)-16.56%

ROA(5y)-17.52%

ROE(3y)-37.72%

ROE(5y)-37.23%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PYR has a better Gross Margin (159.78%) than 100.00% of its industry peers.

PYR's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for PYR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	159.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PYR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for PYR has been increased compared to 1 year ago.

The debt/assets ratio for PYR is higher compared to a year ago.

2.2 Solvency

PYR has an Altman-Z score of 1.33. This is a bad value and indicates that PYR is not financially healthy and even has some risk of bankruptcy.

PYR has a Altman-Z score of 1.33. This is comparable to the rest of the industry: PYR outperforms 40.48% of its industry peers.

PYR has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.

Looking at the Debt to Equity ratio, with a value of 1.61, PYR is doing worse than 64.29% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.61
Debt/FCF	N/A
Altman-Z	1.33

ROIC/WACCN/A

WACC6.42%

2.3 Liquidity

A Current Ratio of 0.68 indicates that PYR may have some problems paying its short term obligations.

PYR has a Current ratio of 0.68. This is in the lower half of the industry: PYR underperforms 78.57% of its industry peers.

PYR has a Quick Ratio of 0.68. This is a bad value and indicates that PYR is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of PYR (0.51) is worse than 80.95% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.68
Quick Ratio	0.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PYR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.53%.

Looking at the last year, PYR shows a very strong growth in Revenue. The Revenue has grown by 90.75%.

PYR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.91% yearly.

EPS 1Y (TTM)6.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-56.92%

Revenue 1Y (TTM)90.75%

Revenue growth 3Y29.92%

Revenue growth 5YN/A

Sales Q2Q%103.79%

3.2 Future

PYR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.63% yearly.

The Revenue is expected to grow by 104.03% on average over the next years. This is a very strong growth

EPS Next Y2.31%

EPS Next 2Y9.84%

EPS Next 3Y14.25%

EPS Next 5Y23.63%

Revenue Next Year150%

Revenue Next 2Y228.89%

Revenue Next 3Y183.57%

Revenue Next 5Y104.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PYR. In the last year negative earnings were reported.

Also next year PYR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PYR's earnings are expected to grow with 14.25% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y9.84%

EPS Next 3Y14.25%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PYR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PYRUM INNOVATIONS AG

FRA:PYR (11/27/2025, 7:00:00 PM)

28.2

+0.4 (+1.44%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)11-22 2024-11-22

Earnings (Next)N/A N/A

Inst Owners1.07%

Inst Owner ChangeN/A

Ins Owners16.54%

Ins Owner ChangeN/A

Market Cap107.72M

Revenue(TTM)2.58M

Net Income(TTM)-9.94M

Analysts82.86

Price Target57.12 (102.55%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)25.7%

PT rev (3m)25.7%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-1.56%

EPS NY rev (3m)-1.56%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.22%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	41.74
P/FCF	N/A
P/OCF	N/A
P/B	5.98
P/tB	8.03
EV/EBITDA	N/A

EPS(TTM)-2.84

EYN/A

EPS(NY)-2.32

Fwd EYN/A

FCF(TTM)-3.6

FCFYN/A

OCF(TTM)-1.25

OCFYN/A

SpS0.68

BVpS4.71

TBVpS3.51

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-16.3%
ROE	-55.22%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	159.78%
FCFM	N/A

ROA(3y)-16.56%

ROA(5y)-17.52%

ROE(3y)-37.72%

ROE(5y)-37.23%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5YN/A

F-Score5

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	1.61
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	257.31%
Cap/Sales	347.91%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.68
Quick Ratio	0.51
Altman-Z	1.33

F-Score5

WACC6.42%

ROIC/WACCN/A

Cap/Depr(3y)569.11%

Cap/Depr(5y)414.55%

Cap/Sales(3y)1213.37%

Cap/Sales(5y)858.81%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)6.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-56.92%

EPS Next Y2.31%

EPS Next 2Y9.84%

EPS Next 3Y14.25%

EPS Next 5Y23.63%

Revenue 1Y (TTM)90.75%

Revenue growth 3Y29.92%

Revenue growth 5YN/A

Sales Q2Q%103.79%

Revenue Next Year150%

Revenue Next 2Y228.89%

Revenue Next 3Y183.57%

Revenue Next 5Y104.03%

EBIT growth 1Y8.65%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year46.8%

EBIT Next 3Y48.39%

EBIT Next 5Y46.24%

FCF growth 1Y38.91%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y21.39%

OCF growth 3YN/A

OCF growth 5YN/A

PYRUM INNOVATIONS AG / PYR.DE FAQ

What is the fundamental rating for PYR stock?

ChartMill assigns a fundamental rating of 2 / 10 to PYR.DE.

What is the valuation status of PYRUM INNOVATIONS AG (PYR.DE) stock?

ChartMill assigns a valuation rating of 0 / 10 to PYRUM INNOVATIONS AG (PYR.DE). This can be considered as Overvalued.

What is the profitability of PYR stock?

PYRUM INNOVATIONS AG (PYR.DE) has a profitability rating of 1 / 10.

What is the expected EPS growth for PYRUM INNOVATIONS AG (PYR.DE) stock?

The Earnings per Share (EPS) of PYRUM INNOVATIONS AG (PYR.DE) is expected to grow by 2.31% in the next year.

PYRUM INNOVATIONS AG (PYR.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PYRUM INNOVATIONS AG / PYR.DE FAQ

What is the fundamental rating for PYR stock?

What is the valuation status of PYRUM INNOVATIONS AG (PYR.DE) stock?

What is the profitability of PYR stock?

What is the expected EPS growth for PYRUM INNOVATIONS AG (PYR.DE) stock?